Your Denial Letter Is a Roadmap: Reading Insurance Rejections Strategically

GLP-1 Prescriptions Editorial Team · July 17, 2026 · 8 min read
Affiliate Disclosure: This site contains affiliate links to telehealth providers. If you click a link and make a purchase, we may receive a commission at no extra cost to you. All opinions are our own. Links marked "Paid link" are sponsored placements. See our full disclosure.

The Denial Letter Tells You Exactly What to Do Next

An insurance denial for a GLP-1 prescription feels like a dead end. It's actually a roadmap. Every denial letter is legally required to state the specific reason for rejection — and that reason tells you exactly what needs to change for the next submission to succeed.

Most patients read the denial, feel defeated, and either give up on insurance coverage or switch to cash-pay. That's understandable but often premature. Denial letters are not final decisions. They're the opening position in a negotiation that you can win — if you understand the rules.

Here's how to read your denial like a claims strategist rather than a disappointed patient.

The Five Most Common Denial Reasons and Their Solutions

1. "Not medically necessary"

What it means: The insurer doesn't think your submitted documentation meets their criteria for GLP-1 prescribing. What to do: Ask your prescriber to submit additional documentation — comorbidity records, BMI history, prior treatment attempts, and a detailed letter of medical necessity that specifically addresses the insurer's clinical policy.

2. "Step therapy not completed"

What it means: You haven't documented trying the required prior treatments. What to do: Either complete the steps (with documentation) or request a step therapy exception with clinical justification.

3. "Prior authorization not obtained"

What it means: The prescription was submitted without the required prior auth. What to do: Have your prescriber submit the PA form. This is a procedural issue, not a coverage denial.

4. "Not on formulary"

What it means: The specific medication isn't on your plan's approved drug list. What to do: Check whether an alternative GLP-1 is on formulary (Wegovy vs. Zepbound, or vice versa), or request a formulary exception.

5. "Exclusion for weight loss indication"

What it means: Your plan specifically excludes anti-obesity medications. What to do: This is the hardest denial to overturn. Your options are appealing based on a non-weight-loss indication (diabetes, cardiovascular risk), requesting a benefit exception, or pursuing cash-pay alternatives.

Editor's Choice

Embody

Top Pick — $400 CPA

From $249/mo

Injectable semaglutide only. Compounded — not FDA-approved.

Check Eligibility →

Building an Appeal That Works

An effective GLP-1 appeal has three components:

Component 1: Address the specific denial reason. Don't submit a generic appeal. If the denial says "step therapy not completed," your appeal must document either completed steps or a valid exception reason. If it says "not medically necessary," your appeal must provide the clinical evidence the insurer said was missing.

Component 2: Clinical documentation. Include recent lab results (A1C, lipid panel, metabolic panel), documented BMI history, records of prior treatment attempts, and any specialist evaluations. The more clinical data, the stronger the appeal.

Component 3: A physician letter of medical necessity. This is your prescriber's clinical argument for why GLP-1 treatment is appropriate for you specifically. The letter should reference current clinical guidelines (AMA, Endocrine Society, Obesity Medicine Association), cite your specific comorbidities and prior treatment history, and explain why alternative treatments are insufficient.

Key Insight: Many successful appeals include a reference to the insurer's own clinical policy document. Call the insurer, request their clinical policy for anti-obesity medications, and make sure your appeal addresses every criterion in that document. You're essentially showing them that you meet their own rules.

Timeline and Escalation

Insurance appeals follow a structured timeline:

First-level appeal: Submit within 180 days of the denial (most plans). Response time: 30 days for standard, 72 hours for urgent/expedited. Success rate for GLP-1 appeals: roughly 40-50% when well-documented.

Second-level appeal: If the first appeal is denied, you can request a second review, often by a different medical reviewer. Some plans allow you to submit additional documentation at this stage.

External review: If internal appeals are exhausted, you have the right to an independent external review by a third-party organization. The external reviewer's decision is binding on the insurer. This is your strongest leverage point, and external reviewers overturn denials more often than most patients realize.

While the appeal is pending, you're not stuck waiting. You can start treatment through cash-pay telehealth and continue pursuing insurance coverage simultaneously. If the appeal eventually succeeds, some plans will reimburse prior out-of-pocket costs — though this varies significantly by insurer.

Brand-Name Rx

Sesame Care

Brand-Name Marketplace

From $99/visit

FDA-approved brand-name medications only (Wegovy, Zepbound, Foundayo). Not compounded.

Check Eligibility →
$100 Off

Found Health

$100 Off Promo

From $129/mo

Compounded — not FDA-approved.

Check Eligibility →
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with potential side effects including nausea, vomiting, diarrhea, and in rare cases, pancreatitis or thyroid tumors. Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Always consult a licensed healthcare provider before starting any medication. Compounded medications are not FDA-approved for safety, efficacy, or quality.